Skip to main content

Peer Review reports

From: Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma

Original Submission
4 Jun 2020 Submitted Original manuscript
27 Jul 2020 Reviewed Reviewer Report
6 Sep 2020 Reviewed Reviewer Report
23 Sep 2020 Author responded Author comments - Ying Chen
Resubmission - Version 2
23 Sep 2020 Submitted Manuscript version 2
13 Oct 2020 Author responded Author comments - Ying Chen
Resubmission - Version 3
13 Oct 2020 Submitted Manuscript version 3
Publishing
16 Oct 2020 Editorially accepted
21 Oct 2020 Article published 10.1186/s12885-020-07536-3

You can find further information about peer review here.

Back to article page